Vanguard Group’s Mateon Therapeutics, Inc. MATN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-787,313
Closed -$489K 4101
2016
Q3
$489K Sell
787,313
-2,300
-0.3% -$1.56K ﹤0.01% 3761
2016
Q2
$553K Buy
+789,613
New +$559K ﹤0.01% 3769

Other funds holding MATN